United Therapeutics Corporation Accumulated Other Comprehensive Income
United Therapeutics Corporation (UTHR) had Accumulated Other Comprehensive Income of -$16.20 million as of 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Balance Sheet › Equity › Equity, Attributable to Parent › Accumulated Other Comprehensive Income (Loss), Net of Tax
us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax · last filed 2026-08-05
- 2026-06-30: Accumulated Other Comprehensive Income (Loss), Net of Tax -$16.20M.
- 2026-03-31: Accumulated Other Comprehensive Income (Loss), Net of Tax -$10.20M.
- 2025-12-31: Accumulated Other Comprehensive Income (Loss), Net of Tax $900.00K.
- 2025-09-30: Accumulated Other Comprehensive Income (Loss), Net of Tax $100.00K.
| Period end | Accumulated Other Comprehensive Income (Loss), Net of Tax | Accumulated Other Comprehensive Income (Loss), Net of Tax as first filed |
|---|---|---|
| 2026-06-30 | -$16.20M 10-Q · filed 2026-08-05 | |
| 2026-03-31 | -$10.20M 10-Q · filed 2026-05-06 | |
| 2025-12-31 | $900.00K 10-Q · filed 2026-08-05 | |
| 2025-09-30 | $100.00K 10-Q · filed 2025-10-29 | |
| 2025-06-30 | $0.00 10-Q · filed 2025-07-30 | |
| 2025-03-31 | -$1.20M 10-Q · filed 2025-04-30 | |
| 2024-12-31 | -$3.40M 10-K · filed 2026-02-25 | |
| 2024-09-30 | $7.40M 10-Q · filed 2024-10-30 | |
| 2024-06-30 | -$14.90M 10-Q · filed 2024-07-31 | |
| 2024-03-31 | -$15.60M 10-Q · filed 2024-05-01 | |
| 2023-12-31 | -$12.80M 10-K · filed 2025-02-26 | |
| 2023-09-30 | -$43.70M 10-Q · filed 2023-11-01 | |
| 2023-06-30 | -$50.60M 10-Q · filed 2023-08-02 | |
| 2023-03-31 | -$38.80M 10-Q · filed 2023-05-03 | |
| 2022-12-31 | -$55.50M 10-K · filed 2024-02-21 | |
| 2022-09-30 | -$84.10M 10-Q · filed 2022-11-02 | |
| 2022-06-30 | -$65.50M 10-Q · filed 2022-08-03 | |
| 2022-03-31 | -$54.30M 10-Q · filed 2022-05-04 | |
| 2021-12-31 | -$23.00M 10-K · filed 2023-02-22 | |
| 2021-09-30 | -$20.10M 10-Q · filed 2021-11-03 | |
| 2021-06-30 | -$18.60M 10-Q · filed 2021-08-04 | |
| 2021-03-31 | -$16.80M 10-Q · filed 2021-05-05 | |
| 2020-12-31 | -$14.20M 10-K · filed 2022-02-24 | |
| 2020-09-30 | -$4.50M 10-Q · filed 2020-10-28 | |
| 2020-06-30 | -$2.10M 10-Q · filed 2020-07-29 | |
| 2020-03-31 | -$3.50M 10-Q · filed 2020-04-29 | |
| 2019-12-31 | -$14.20M 10-K · filed 2021-02-24 | |
| 2019-09-30 | -$4.10M 10-Q · filed 2019-10-30 | |
| 2019-06-30 | -$5.00M 10-Q · filed 2019-07-31 | |
| 2019-03-31 | -$5.20M 10-Q · filed 2019-05-01 | |
| 2018-12-31 | -$7.90M 10-K · filed 2020-02-26 | |
| 2018-09-30 | -$22.20M 10-Q · filed 2018-10-31 | |
| 2018-06-30 | -$21.90M 10-Q · filed 2018-08-01 | |
| 2018-03-31 | -$21.70M 10-Q · filed 2018-05-02 | |
| 2017-12-31 | -$19.60M 10-K · filed 2019-02-27 | |
| 2017-09-30 | -$16.80M 10-Q · filed 2017-10-25 | |
| 2017-06-30 | -$16.60M 10-Q · filed 2017-07-27 | |
| 2017-03-31 | -$16.70M 10-Q · filed 2017-04-26 | |
| 2016-12-31 | -$16.80M 10-K · filed 2018-02-21 | |
| 2016-09-30 | -$16.80M 10-Q · filed 2016-10-27 | |
| 2016-06-30 | -$14.70M 10-Q · filed 2016-07-28 | |
| 2016-03-31 | -$19.80M 10-Q · filed 2016-04-28 | |
| 2015-12-31 | -$20.40M 10-K · filed 2017-02-22 | -$20.40M 10-K · filed 2016-02-25 |
| 2015-09-30 | -$21.93M 10-Q · filed 2015-10-27 | |
| 2015-06-30 | -$19.93M 10-Q · filed 2015-07-28 | |
| 2015-03-31 | -$21.64M 10-Q · filed 2015-04-28 | |
| 2014-12-31 | -$16.73M 10-K · filed 2016-02-25 | |
| 2014-09-30 | -$16.93M 10-Q · filed 2014-10-28 | |
| 2014-06-30 | -$14.63M 10-Q · filed 2014-07-29 | |
| 2014-03-31 | -$15.64M 10-Q · filed 2014-04-29 | |
| 2013-12-31 | -$13.18M 10-K · filed 2015-02-24 | |
| 2013-09-30 | -$15.06M 10-Q · filed 2013-10-29 | |
| 2013-06-30 | -$17.11M 10-Q · filed 2013-07-25 | |
| 2013-03-31 | -$16.96M 10-Q · filed 2013-04-25 | |
| 2012-12-31 | -$14.96M 10-K · filed 2014-02-25 | |
| 2012-09-30 | -$9.52M 10-Q · filed 2012-11-01 | |
| 2012-06-30 | -$10.91M 10-Q · filed 2012-07-26 | |
| 2012-03-31 | -$9.54M 10-Q · filed 2012-04-26 | |
| 2011-12-31 | -$10.88M 10-K · filed 2013-02-26 | |
| 2011-09-30 | -$10.64M 10-Q · filed 2011-10-27 | |
| 2011-06-30 | -$8.52M 10-Q · filed 2011-07-28 | |
| 2011-03-31 | -$7.33M 10-Q · filed 2011-04-28 | |
| 2010-12-31 | -$9.18M 10-K · filed 2012-02-28 | |
| 2010-09-30 | -$6.19M 10-Q · filed 2010-10-28 | |
| 2010-06-30 | -$7.22M 10-Q · filed 2010-07-28 | |
| 2009-12-31 | -$4.31M 10-K · filed 2011-02-24 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Viatris Inc (VTRS) | United States | $20.008B | -0.00 |
| Royalty Pharma plc (RPRX) | United States | $22.628B | |
| Jazz Pharmaceuticals plc (JAZZ) | $15.333B | 16.07 | |
| Roivant Sciences Ltd. (ROIV) | $26.105B | -96.08 | |
| INSMED Inc (INSM) | United States | $26.566B | -26.60 |
| Summit Therapeutics Inc. (SMMT) | United States | $13.071B | -13.21 |
| BridgeBio Pharma, Inc. (BBIO) | United States | $12.947B | -20.72 |
| CORCEPT THERAPEUTICS INC (CORT) | United States | $12.804B | 169.10 |
| BIOMARIN PHARMACEUTICAL INC (BMRN) | United States | $11.879B | 151.80 |
| MADRIGAL PHARMACEUTICALS, INC. (MDGL) | United States | $11.859B | -38.17 |